Optomed Oyj
Nasdaq Helsinki · LEI 7437009IVYWGEE4S7B77· Fiscal year 2025
Staff cost per employee
Not disclosed
Employees
Not disclosed
Quick read
- Revenue grew 13.7% year over year.
- Operating loss of $6.6M in 2025.
Last 3 years
Revenue
Operating income
See the share price on Google Finance ↗
Investor metrics
2025
- Operating margin
- -35.3%
- Net margin
- -38.8%
- ROE
- -27.6%
- Debt-to-equity
- 33.1%
- Equity ratio
- 75.1%